Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. gene cell therapy
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Gene Cell Therapy Articles & Analysis

243 news found

With two in five employees undergoing fertility treatment leaving their jobs or considering quitting, are companies doing enough?

With two in five employees undergoing fertility treatment leaving their jobs or considering quitting, are companies doing enough?

An international survey from Ferring, Fertility Matters at Work and This Can Happen reveals a significant gap exists between employees and employers in recognising the experience of undergoing fertility treatment1 Nearly all employees say fertility treatment impacts their mental health, yet only one third feel supported by their employer’s fertility policies1 Around the world, ...

ByFerring Pharmaceuticals


BOC Sciences Joins Forces with Innovators at PODD Conference 2025

BOC Sciences Joins Forces with Innovators at PODD Conference 2025

BOC Sciences is teaming up with innovators at the PODD Conference 2025 to fast-track the next generation of drug delivery. The future of medicine rests, in large part, on effective delivery systems. With the industry rushing to harness the potential of advanced therapeutics — from gene therapies to mRNA vaccines — most key breakthroughs are gated by a singular challenge: delivering ...

ByBOC Sciences


Amerigo Scientific Delivers Highly Efficient Transfection Reagents Coming with Detailed Selection Guide

Amerigo Scientific Delivers Highly Efficient Transfection Reagents Coming with Detailed Selection Guide

In many research applications, such as gene expression studies, vaccine development, and gene therapy, transfection—the process of introducing nucleic acids into cells—is an essential step. Despite the advances in transfection technologies, choosing the appropriate reagents for particular cell types ...

ByAmerigo Scientific


Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

About Protheragen Protheragen specializes in providing a range of preclinical research services for rare disease research, addressing many of the challenges encountered in drug discovery and development. Its end-to-end rare disease therapy development solutions cover a full package of therapeutic development services, which include small molecule, cell ...

ByProtheragen


Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

As of the latest research, several experimental gene therapies for glaucoma are in various stages of development, from preclinical studies to early-phase clinical trials. ...

ByAce Therapeutics


Biopharma PEG Expands GMP Production of Lipids and PEGs to Meet Growing Demand for Lipid Nanoparticles

Biopharma PEG Expands GMP Production of Lipids and PEGs to Meet Growing Demand for Lipid Nanoparticles

They are essential for the efficient transportation of mRNA to target cells, ensuring that therapeutic mRNA is delivered to the cytoplasm, where it can effectively produce the target protein. ...

ByBiopharma PEG Scientific Inc


Advanced Instruments Named One of the Top 10 Cell and Gene Therapy Companies in Europe

Advanced Instruments Named One of the Top 10 Cell and Gene Therapy Companies in Europe

Advanced Instruments, a leading provider of analytical instruments and services for clinical and biopharmaceutical laboratories, is proud to announce the expansion of its Artel portfolio’s direct presence in Austria, France, Germany, and Switzerland. This strategic move underscores Advanced Instruments’ commitment to providing unparalleled access to their liquid volume verification ...

ByAdvanced Instruments


BOC Sciences Adds Exosome-Related Technologies to Back Up RNA Drug Delivery

BOC Sciences Adds Exosome-Related Technologies to Back Up RNA Drug Delivery

Exosomes are tiny vesicles secreted by cells, capable of transporting molecules from one cell to another. They play an essential role in intercellular communication and hold high potential as drug delivery systems due to their natural ability to carry and deliver substances within the body. ...

ByBOC Sciences


Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study

Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...

ByBCC Research


Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks

Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks

HCPs are native proteins of CHO cells released in the cell culture supernatant through secretion or cell lysis upon death. ...

ByAdvanced Instruments


Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research

Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research

As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. ...

ByProtheragen


CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications

CD Formulation, a leading provider of innovative pharmaceutical formulation services, has recently launched a comprehensive range of microsphere and microneedle solutions for pharmaceutical and biotech applications. The newly introduced solutions are focused on long-acting controlled-release microspheres and phase-transition microneedle patches, to meet the growing demand for novel ...

ByCD Formulation


CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance ...

ByCD Formulation


CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently introduced a line of highly efficient mRNA Transfection Reagents with low toxicity for research applications, including the mRNA Transfection Reagent, Stem mRNA Transfection Reagent, and mRNA/gRNA Transfection Reagent. mRNA transfection is the process of introducing and expressing mRNA ...

ByCD Bioparticles


Emerging Trends in the BioPharma Industry that you Need to Know

Emerging Trends in the BioPharma Industry that you Need to Know

Emerging trends in the biopharma industry include new developments in cancer treatments, advances in gene therapy, and more data-driven decision-making. As a leader in the sector, it’s important to be aware of these developments to make informed decisions about your organization’s direction. In this blog post, we’ll explore some of the most significant emerging trends in ...

ByBrio Group


CELLVIE closes $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation

CELLVIE closes $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation

They are commonly known as the powerhouses of the cell, generating most of its needed energy and operating as critical intra-cellular communication nodes. ...

Bycellvie Inc.


Viral Vector Manufacturing

Viral Vector Manufacturing

In recent years, applications of viral vectors have found an encouraging new beginning in gene therapy and in vaccine development. What can viral vectors be used for? ...

ByNuvonis


ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline

ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline

ViGeneron GmbH, a gene therapy company, announced the closing of its series A financing round led by WuXi AppTec and Sequoia Capital China. The proceeds will enable ViGeneron to accelerate its proprietary viral vector-based gene therapy platforms and drive product development in its two lead ophthalmic gene ...

ByViGeneron GmbH


ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT

ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT

VG801 is based on the Company’s novel adeno-associated virus (AAV) technology platforms, enabling the efficient expression of large genes in retinal photoreceptors after intravitreal injection. The data from a Stargardt disease model will be presented in a poster session at the European Society of Gene & Cell Therapy ...

ByViGeneron GmbH


Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

“In addition, positive study outcomes from our cell & gene therapy platforms offer a potential upside that is hard to quantify exactly today but can reach multi-billion Euro ...

ByBayer AG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT